Month: August 2022

INVESTOR NEWS no. 24 – 16 August 2022 Ferry – freight: Total volumes in July 2022 were 6.2% below 2021. Activity was overall robust in freight markets except for parts of the Baltic Sea region and the Channel Dover Strait corridor. North Sea volumes were overall below 2021 as UK routes were on level while routes between Sweden and the Continent were below 2021. The latter decrease was due to lower automotive and paper volumes as well as high activity for these segments last year in July. Volumes in the Mediterranean network continued to grow reflecting a high level of Turkish industrial production and exports. Channel’s volumes were below 2021 following a decrease in total market volumes. Baltic Sea’s volumes were below 2021 due to the war in Ukraine. Volumes were mainly lower between Germany and Lithuania. For the last twelve...

INVESTOR NEWS no. 24 – 16 August 2022 Ferry – freight: Total volumes in July 2022 were 6.2% below 2021. Activity was overall robust in freight markets except for parts of the Baltic Sea region and the Channel Dover Strait corridor. North Sea volumes were overall below 2021 as UK routes were on level while routes between Sweden and the Continent were below 2021. The latter decrease was due to lower automotive and paper volumes as well as high activity for these segments last year in July. Volumes in the Mediterranean network continued to grow reflecting a high level of Turkish industrial production and exports. Channel’s volumes were below 2021 following a decrease in total market volumes. Baltic Sea’s volumes were below 2021 due to the war in Ukraine. Volumes were mainly lower between Germany and Lithuania. For the last twelve...

HS2 designers on track to more than halve the amount of embedded carbon as foundation work begins on one of the project’s main viaducts Innovative construction approach set to save an estimated 7,433 tons of carbon – the equivalent of 20,500 return flights from London to Edinburgh Arcadis JV involved in pioneering approach inspired by French high-speed lines16 August, 2022 – HS2, Britain’s new high speed railway line and the largest infrastructure project in Europe, has taken another step forward with the commencement of works on the pioneering low-carbon Wendover Dean Viaduct. At 450m-long, the viaduct will be the first major railway bridge in the UK to be built with a ‘double composite’ structure, using significantly less carbon-intensive concrete and steel in comparison to a more traditional design. The ‘double composite’ approach...

Kyivstar to bring Digital Health Services to All Ukrainians, both home and abroad, as part of its commitment to the rebuilding of the countryAmsterdam, 16 August 2022: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and services, today announces that its subsidiary in Ukraine, Kyivstar, is to launch a national digital health service and make it available to all Ukrainians as part of the country’s Digital Ukraine strategy.Kyivstar, Ukraine’s largest digital operator with 24.8 million mobile subscribers and over 1.2 million home internet subscribers as of June 2022, has acquired a controlling stake in Helsi Ukraine, the country’s largest medical information system and leading digital healthcare provider.  The strategic investment is part Kyivstar’s commitment to the rebuilding...

First new treatment regimen in more than 20 years to significantly improve outcomes in people with this fast-growing type of lymphoma Application is based on pivotal data from the phase III POLARIX study showing Polivy plus R-CHP significantly reduced the risk of disease progression, relapse or death with comparable safety versus the standard of care, R-CHOP Various combination studies with Polivy and the company’s CD20xCD3 bispecifics in diffuse large B-cell lymphoma are ongoingBasel, 16 August 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Polivy® (polatuzumab vedotin-piiq) in combination with Rituxan® (rituximab) plus cyclophosphamide, doxorubicin and prednisone (R-CHP) for the...

CHF 29 million royalty income (+22.5% year-on-year) reflecting continued commercial success of Cresemba Continued improvement of operating cash flow CHF 142 million cash, restricted cash and investments at half-year 2022 Full-year 2022 guidance confirmed as well as expected sustainable profitability from 2023Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, August 16, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today its results for the first half-year ended June 30, 2022. David Veitch, Chief Executive Officer, stated: “We have made significant progress in the implementation of our new strategy. We have extended our pipeline by in-licensing a potential first-in-class preclinical antifungal project. We also made good progress on the separation of our oncology...

Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, France Latest expansions represent Myriad’s commitment to growing international lab partner programSALT LAKE CITY, Aug. 16, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two partnerships with the Institut für Hämopathologie Hamburg (HPH) in Hamburg, Germany and the Centre Georges-Francois LeClerc (CGFL) in Dijon, France to expand access to MyChoice® CDx Plus testing. HPH and CGFL join Myriad’s network of partner laboratories to help support equitable patient access to genetic testing in key European markets. MyChoice CDx Plus is a CE-IVD-marked companion diagnostic test that determines Homologous Recombination Deficiency (HRD) status in women with ovarian cancer. Determining...